APA (7th ed.) Citation

Testa, A. C., Moro, F., Pasciuto, T., Moruzzi, M. C., Di Legge, A., Fuoco, G., . . . Di Legge, A. (2018). Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: The role of ultrasound after chemoradiation to assess residual tumor. Ultrasound in Obstetrics & Gynecology, 52(1), 110. https://doi.org/10.1002/uog.18953

Chicago Style (17th ed.) Citation

Testa, A. C., et al. "Prospective Multimodal Imaging Assessment of Locally Advanced Cervical Cancer Patients Administered by Chemoradiation Followed by Radical Surgery. The PRICE (PRospective Imaging of CErvical Cancer and Neoadjuvant Treatment) Study 2: The Role of Ultrasound After Chemoradiation to Assess Residual Tumor." Ultrasound in Obstetrics & Gynecology 52, no. 1 (2018): 110. https://doi.org/10.1002/uog.18953.

MLA (9th ed.) Citation

Testa, A. C., et al. "Prospective Multimodal Imaging Assessment of Locally Advanced Cervical Cancer Patients Administered by Chemoradiation Followed by Radical Surgery. The PRICE (PRospective Imaging of CErvical Cancer and Neoadjuvant Treatment) Study 2: The Role of Ultrasound After Chemoradiation to Assess Residual Tumor." Ultrasound in Obstetrics & Gynecology, vol. 52, no. 1, 2018, p. 110, https://doi.org/10.1002/uog.18953.